Ibrutinib Regimens in Older Patients with Untreated CLL. Reply
N Engl J Med
.
2019 Apr 25;380(17):1680-1681.
doi: 10.1056/NEJMc1901284.
Authors
Jennifer A Woyach
1
,
Amy S Ruppert
1
,
Sumithra J Mandrekar
2
Affiliations
1
Ohio State University, Columbus, OH jennifer.woyach@osumc.edu.
2
Mayo Clinic, Rochester, MN.
PMID:
31018081
DOI:
10.1056/NEJMc1901284
No abstract available
Publication types
Letter
Comment
MeSH terms
Adenine / analogs & derivatives
Aged
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Piperidines
Pyrazoles*
Pyrimidines*
Substances
Piperidines
Pyrazoles
Pyrimidines
ibrutinib
Adenine
Grants and funding
P30 CA016058/CA/NCI NIH HHS/United States